Biotech ETFs can Cope With the new White House

Biotech ETFs can Cope With the new White House


The healthcare sector was a laggard last year, but the iShares Nasdaq Biotechnology ETF , SPDR S&P Biotech ETF and other biotechnology exchange traded funds are shaking out of that slumber with some solid gains in 2017's early stages.



from Biotech News